Medical Nutrition

SATIN chief: “...even if not combined with another effective mono-therapy it could become a very powerful tool.”

"We hope to develop a pill for fexaramine within 24 to 36 months to try in humans."

Satiety pill shows metabolic syndrome potential: Mice study

By Shane STARLING

The mainstream press has latched onto a mouse study that shows a bile-controlling, gut restricted pharma intervention can mimic food intake and therefore potentially be an obesity beater. But could it pass clinical inspection? One weight loss researcher...

Extra oligofructose and inulin in tube feed doesn't impact bifidobacteria, but does decrease Faecalibacterium prausnitzii and Bacteroides-Prevotella, according to a intensive care ward study

Researchers question extra prebiotic use in enteral nutrition

By Annie Harrison-Dunn

Additional prebiotics oligofructose and inulin through enteral nutrition does not significantly impact faecal concentrations of ‘friendly bacteria’ bifidobacteria in intensive-care patients, according to research.

Health claims panel memeber Hans Verhagen told HiE delegates that he thinks 'everybody would love to see at least one approved health claim ... at some point in time,”

"I think everybody would love to see at least one approved health claim in these areas at some point in time”

EFSA claim for pro- and prebiotics getting closer, but industry is wary of rushing

By Nathan Gray

There is a general feeling that probiotic and prebiotic producers are getting closer to receiving their categories' first ever health claim; however many big companies are wary of rushing applications after learning the lessons from previous failed...

Alterations to our gut microbiota may influence the blood-brain barrier - playing a role in protecting the brain, say researchers.

Gut bacteria may play role in brain protection

By Nathan GRAY

Our natural gut-residing microbes could play a role in controlling the permeability of the blood-brain barrier - which protects the brain from harmful substances in the blood, say researchers.

BASF sells Norwegian omega-3 business to US firm

BASF sells Norwegian omega-3 business to US firm

By Shane STARLING

BASF has sold its Norwegian, “natural fish oils, medium-concentrated omega-3s, and customised bottled fish oil” plant to Pennsylvania firm Marine Ingredients for an undisclosed sum as the German ingredients and chemicals giant switches its focus to high-end...

Mellentin:

Special edition: Functional foods

Phood booed: Why big pharma fails at functional food

By Julian Mellentin

Faced with mounting difficulties in their drug businesses, many pharmaceutical manufacturers are looking at getting into functional foods and beverages, notes food marketing expert, Julian Mellentin in this guest article.

Follow us

Products

View more

Webinars